MindLife just won a large Innovate UK grant competition to develop the next generation of effective, scalable solutions to treat common mental health issues, including covering the cost of 2 large clinical trials to demonstrate that MindLife solutions are more effective and cost-effective than existing methods.
The Innovate UK Biomedical Catalyst grant programme is a UK government initiative that supports the development of innovative healthcare technologies and treatments. The programme funds projects that improve patient outcomes create new jobs, and boost the UK’s economy.
The grant programme is open to UK-based small and medium-sized enterprises (SMEs), academic researchers, and charities. Successful applicants receive funding to carry out research and development projects that have the potential to impact the healthcare industry significantly.
Projects supported by the Biomedical Catalyst programme include the development of new drugs and medical devices, as well as the creation of innovative diagnostic tools and treatments. The programme also supports projects that aim to improve the efficiency and effectiveness of healthcare services.
Tuvi Orbach, Founder and CEO of MindLife UK said, “The Innovate UK Biomedical Catalyst grant programme is an excellent opportunity for SMEs and researchers to receive funding and support for innovative healthcare projects. MindLife UK, together with our NHS-Trust and British university partners, are delighted to have been awarded this grant to promote our industry-led R&D. It is a stamp of approval that our solution is innovative, answering a very important need that contributes to the economy, and will make a real difference in patients’ lives.”
Winning the Innovate UK Biomedical Catalyst grant delivers to MindLife UK key advantages:
- Covering the costs of large clinical trials to show that our solutions are more effective and cost-effective than existing solutions.
- Covering 70% of the costs of our R&D to complete UpLift Your Life
- Covers the cost of NHS Trust and University researchers who collaborate with us in delivering this scientifically validated solution.